First Clinical Trial with Iohexol in Myelography
- 1 November 1983
- journal article
- research article
- Published by SAGE Publications in Acta Radiologica. Diagnosis
- Vol. 24 (6) , 499-502
- https://doi.org/10.1177/028418518302400612
Abstract
The 1st clinical trial with iohexol in lumbar myelography was carried out as an open, non-comparative study in 30 patients and was part of a multicenter trial. Iohexol doses of 10-15 ml (180 mg I/ml) were used and clinical and laboratory tests were performed before and during 48 h after myelography. Spinal repuncture 6 or 24 h after myelography was done in all patients. Only minor side effects of temporary duration were recorded in 8 patients. No seizures or spikes on EEG were seen. There was no significant increase in CSF parameters such as white cell counts, protein or IgG.This publication has 3 references indexed in Scilit:
- The diagnostic value of measuring creatine kinase BB activity in cerebrospinal fluid following acute head injuryActa Neurochirurgica, 1982
- Effects of Ca, Mg, and EDTA on creatine kinase activity in cerebrospinal fluid.Clinical Chemistry, 1979
- Lumbar Myelography with Meglumine Iocarmate and MetrizamideActa Radiologica. Diagnosis, 1975